000 | 00994 a2200277 4500 | ||
---|---|---|---|
005 | 20250516231549.0 | ||
264 | 0 | _c20140908 | |
008 | 201409s 0 0 jpn d | ||
022 | _a0385-0684 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aNakada, Mitsutoshi | |
245 | 0 | 0 |
_a[Drug repositioning in neuro-oncology-targeting GSK3β for glioblastoma]. _h[electronic resource] |
260 |
_bGan to kagaku ryoho. Cancer & chemotherapy _cJun 2014 |
||
300 |
_a720-4 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aDisease Progression |
650 | 0 | 4 | _aDrug Repositioning |
650 | 0 | 4 |
_aGlioblastoma _xdiagnosis |
650 | 0 | 4 |
_aGlycogen Synthase Kinase 3 _xantagonists & inhibitors |
650 | 0 | 4 | _aGlycogen Synthase Kinase 3 beta |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aNeoplasm Invasiveness |
650 | 0 | 4 |
_aProtein Kinase Inhibitors _xtherapeutic use |
700 | 1 | _aMinamoto, Toshinari | |
773 | 0 |
_tGan to kagaku ryoho. Cancer & chemotherapy _gvol. 41 _gno. 6 _gp. 720-4 |
|
999 |
_c24139966 _d24139966 |